Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upSibylle Loibl, Nadia Harbeck, Michael Gnant et al.|Annals of Oncology|2023Cited by 830
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the BreastLawrence J. Solin, S Badve, Robert P. Gray et al.|JNCI Journal of the National Cancer Institute|2013Cited by 523
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanismGeorge S. Karagiannis, Maja H. Oktay, Jessica Pastoriza et al.|Science Translational Medicine|2017Cited by 507
Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Margaret E. Gatti‐Mays et al.|JAMA Oncology|2019Cited by 409
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and <i>BRCA1</i>/<i>2</i> Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L. Telli, James M. Ford, Kristin C. Jensen et al.|Journal of Clinical Oncology|2015Cited by 226